Tue, 23 September 2014
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
Direct download: 013_-_Obesity_Guidelines_and_Pharmacotherapy.mp3
Category:general -- posted at: 6:00am EST |
Tue, 9 September 2014
In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo). |